Literature DB >> 17600556

In vitro effects of antipsychotics on human platelet adhesion and aggregation and plasma coagulation.

Stina Axelsson1, Staffan Hägg, Andreas C Eriksson, Tomas L Lindahl, Per A Whiss.   

Abstract

1. Several studies suggest an association between venous thromboembolism and the use of antipsychotic drugs, especially clozapine, but the biological mechanisms are unknown. It has been suggested that antipsychotic drugs enhance aggregation of platelets and thereby increase the risk of venous thrombosis. The purpose of the present study was to examine the effects of clozapine and its main metabolite, N-desmethyl clozapine, as well as olanzapine, risperidone and haloperidol, on platelet adhesion and aggregation and on plasma coagulation in vitro. 2. Blood was collected from healthy subjects free of medication. Platelet adhesion to different protein surfaces and aggregation were measured in microplates. The coagulation methods of activated partial thromboplastin time (APTT) and prothrombin time were performed in platelet-poor plasma. 3. Clozapine was the only compound that increased platelet adhesion and aggregation and shortened APTT. The effect appeared at therapeutic concentrations and was significant but weak. 4. This weak effect of clozapine on haemostasis may explain, in part, the association of this compound and venous thromboembolism.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17600556     DOI: 10.1111/j.1440-1681.2007.04650.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  15 in total

Review 1.  Safety of antipsychotics for the treatment of schizophrenia: a focus on the adverse effects of clozapine.

Authors:  Domenico De Berardis; Gabriella Rapini; Luigi Olivieri; Domenico Di Nicola; Carmine Tomasetti; Alessandro Valchera; Michele Fornaro; Fabio Di Fabio; Giampaolo Perna; Marco Di Nicola; Gianluca Serafini; Alessandro Carano; Maurizio Pompili; Federica Vellante; Laura Orsolini; Giovanni Martinotti; Massimo Di Giannantonio
Journal:  Ther Adv Drug Saf       Date:  2018-02-06

2.  In thrombin stimulated human platelets Citalopram, Promethazine, Risperidone, and Ziprasidone, but not Diazepam, may exert their pharmacological effects also through intercalation in membrane phospholipids in a receptor-independent manner.

Authors:  Ramadhan Oruch; Erlend Hodneland; Ian F Pryme; Holm Holmsen
Journal:  J Chem Biol       Date:  2009-04-30

Review 3.  Cardiovascular Disease in Clozapine-Treated Patients: Evidence, Mechanisms and Management.

Authors:  Kathlyn J Ronaldson
Journal:  CNS Drugs       Date:  2017-09       Impact factor: 5.749

Review 4.  Venous thromboembolism in recipients of antipsychotics: incidence, mechanisms and management.

Authors:  Anna K Jönsson; Olav Spigset; Staffan Hägg
Journal:  CNS Drugs       Date:  2012-08-01       Impact factor: 5.749

5.  Olanzapine and pulmonary embolism, a rare association: a case report.

Authors:  Julian Fz Maempel; Geraldine Darmanin; Kashif Naeem; Mehool Patel
Journal:  Cases J       Date:  2010-01-22

6.  Hyperserotonemia in autism: activity of 5HT-associated platelet proteins.

Authors:  Dubravka Hranilović; Zorana Bujas-Petković; Maja Tomicić; Tatjana Bordukalo-Niksić; Sofia Blazević; Lipa Cicin-Sain
Journal:  J Neural Transm (Vienna)       Date:  2009-02-17       Impact factor: 3.575

7.  The dopamine agonism on ADP-stimulated platelets is mediated through D2-like but not D1-like dopamine receptors.

Authors:  Angelika Schedel; Patrick Schloss; Harald Klüter; Peter Bugert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-06-10       Impact factor: 3.000

8.  Associations between venous thromboembolism and antipsychotics. A study of the WHO database of adverse drug reactions.

Authors:  Staffan Hägg; Andrew Bate; Malin Stahl; Olav Spigset
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

Review 9.  Drug-induced thrombosis: an update.

Authors:  Yuval Ramot; Abraham Nyska; Galia Spectre
Journal:  Drug Saf       Date:  2013-08       Impact factor: 5.606

10.  Pulmonary embolism related to amisulpride treatment: a case report.

Authors:  Maria Skokou; Philippos Gourzis
Journal:  Case Rep Psychiatry       Date:  2013-02-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.